腔内激光联合手术治疗下肢静脉曲张的评价

目的 评价腔内激光(EVLT)联合手术治疗下肢静脉曲张的疗效.方法 下肢静脉曲张172例,198条下肢.按不同病因分为3组,采用EVLT 相应手术方法治疗:①A组:原发性下肢深静脉瓣膜功能不全45条患肢,行股浅静脉瓣膜包窄 EVLT 内镜下小腿内侧功能不全交通静脉离断术(SEPS);②B组:轻度原发性深静脉瓣膜功能不全55条下肢,行EVLT SEPS;③C组:单纯性大隐静脉曲张,98条下肢,行EVLT.结果 随访2～44个月,平均32个月,5例有曲张静脉复发,再次行EVLT后未再复发;其余167例症状消退或明显好转,溃疡均愈合,彩超示大隐静脉全程闭合,深静脉通畅.结论 EVLT具有微创、安全、易于操作的特点,联合手术治疗下肢静脉曲张的效果满意.     

内镜深筋膜下穿通静脉离断联合腔内激光治疗下肢静脉曲张

目的: 探讨内镜深筋膜下穿通静脉离断术（subfascial endoscopic perforator surgery, SEPS）联合腔内激光治疗（endovenous laser treatment,EVLT）术治疗下肢静脉曲张的可行性。方法: 2016年8月至2017年10月,静脉顺行造影诊断下肢穿通静脉瓣膜功能不全患肢81条,选择40条患肢行SEPS术,联合EVLT术闭合浅表曲张静脉,保留健康大隐静脉作为研究组;41条患肢作为对照组,行传统大隐静脉高位结扎抽剥术。结果: 研究组曲张静脉团块消失,下肢静脉血淤滞得到缓解,色素沉着减轻,溃疡愈合,随访5~11个月无复发。研究组手术时间少于对照组（1.1 h比3.0 h）,切口数也少于对照组（2.1个比5.8个）,住院时间缩短（1.1 d比3.9 d）,下肢淤斑面积减少（5.2 cm³比20.3 cm³）,差异均有显著统计学意义（P<0.01）。结论: SEPS联合EVLT术适合个体化微创治疗下肢静脉曲张,创伤小、恢复快。     

腔内激光联合手术治疗下肢静脉曲张的实验和临床研究

目的评价改进腔内激光(EVLT)联合手术治疗下肢静脉曲张的疗效。方法下肢静脉曲张90例116条下肢。按病因和病情采用3种手术治疗(1)A组临床表现明显的原发性下肢深静脉瓣膜功能不全24条下肢,作股浅静脉瓣膜包窄 大隐静脉高位结扎 EVLT 内镜下小腿内侧交通静脉离断术SEPS;(2)B组轻度原发性深静脉瓣膜功能不全26条下肢,作大隐静脉高位结扎 EVLT SEPS;(3)C组单纯性大隐静脉曲张66条下肢,作大隐静脉高位结扎 EVLT。结果平均随访20个月,3组患者均无复发,临床症状和体征消退或好转,溃疡均愈合。彩超检查示大隐静脉全程闭合,无血流信号,深静脉回流通畅。结论EVLT具有微创、安全、操作简单和疗效良好的优点,针对病因和病情联合不同手术治疗下肢静脉病变效果满意。     

静脉腔内激光联合手术治疗下肢静脉曲张

目的初步评价腔内激光联合手术治疗下肢静脉曲张的疗效。方法全组下肢静脉曲张患者28例，共38条下肢。按病因和病情的不同，采用3种手术治疗：（1）临床表现明显的原发性下肢深静脉瓣膜功能不全者4条下肢，作股浅静脉瓣膜包窄＋大隐静脉高位结扎＋EVLT＋SEPS术；（2）轻度原发性深静脉瓣膜功能不全者15条下肢，作大隐静脉高位结扎＋EVLT＋SEPS；（3）单纯性大隐静脉曲张者19条下肢，作大隐静脉高位结扎＋EVLT。结果平均随访11个月，全组患者均无复发；临床症状和体征消退或好转，彩超检查示大隐静脉均全程闭合，无血流信号。结论EVLT具有无创、安全、操作简便和疗效良好的优点，联合手术治疗下肢静脉病变的效果满意。     

下肢静脉性溃疡的综合性手术治疗

目的探讨下肢静脉性溃疡综合性手术治疗的价值。方法总结38例(43条肢体)下肢静脉曲张合并静脉性溃疡患者手术治疗的临床资料。全部患者术前都行顺行性深静脉造影。所有患肢均行浅静脉手术和溃疡周围曲张浅静脉缝扎术,其中8条患肢加行深静脉瓣膜修补术,17条患肢加行腔镜深筋膜下交通静脉结扎术即SEPS,9条患肢加行深静脉瓣膜修补术和SEPS。结果术后所有患者的症状消失,溃疡愈合,小腿皮肤的湿疹或色素沉着明显减轻。术后6个月随访,有6条患肢出现溃疡复发,加行SEPS治疗后溃疡愈合。术后1～2年随访,均无静脉性溃疡复发。结论下肢静脉性溃疡是深、浅静脉和交通静脉功能不全共同作用的结果。在治疗下肢静脉性溃疡时,应同时纠正每个静脉系统的功能不全,尤其是交通静脉功能不全。     

腔镜深筋膜下交通静脉离断术治疗下肢静脉性溃疡

目的:探讨腔镜深筋膜下交通静脉离断术(SEPS)治疗下肢静脉性溃疡(VLU)的临床效果。方法:回顾性分析3年半内收治的70例(76条患肢)下肢静脉功能不全患者的临床资料。按CEAP临床分类,其中C4级38例(41条患肢),C5级18例(18条患肢),C6级14例(17条患肢)。18例(18条患肢)C4级患者行大隐静脉高位结扎分段剥脱术(传统组),其余患者采用SEPS联合大隐静脉高位结扎分段剥脱术(SEPS组)。分析患肢手术前后的CEAP临床评分及患肢溃疡愈合时间和复发情况。结果:SEPS组患者术后曲张静脉团消失,患肢酸胀及沉重感逐渐减轻,局部瘙痒及创面疼痛缓解;C5级患者溃疡愈合区色素沉着及硬化明显改善,皮炎消失;C6级患者足靴区活动性溃疡在术后10~60 d(平均47.3 d)愈合;术后患肢的CEAP临床评分均低于术前(均P<0.05);平均随访15个月,无复发患者。SEPS组C4级患者与传统组患者术后各项评分均无统计学差异(均P>0.05)。结论:SEPS是治疗重度下肢静脉功能不全合并VLU的有效方法。     

腹腔镜深筋膜下交通支结扎治疗下肢交通静脉瓣膜功能不全

下肢浅静脉曲张,尤其是合并足靴区广泛性色素沉着、湿疹和溃疡的病人,多数在深静脉及大隐静脉瓣膜关闭不全的基础上合并交通静脉瓣膜功能不全,为准确结扎阻断交通静脉,1985年德国的Hauer首先将腹腔镜技术引入治疗下肢静脉疾病,开展了腔镜筋膜下交通静脉手术(subfascialendoscopicper foratorsurgery,SEPS)。此后,随着腔镜技术不断改进,这种手术的开展越来越广泛。我院采用SEPS治疗下肢交通静脉瓣膜功能不全5例,疗效满意,现报告如下。1临床资料1.1一般资料:2002年10月～2004年3月收治5例交通静脉瓣膜功能不全病人,均存在深静脉及大隐静脉…     

腔内射频联合激光和手术治疗下肢静脉功能不全的初步报道

目的评价腔内射频联合激光和手术治疗下肢静脉功能不全的安全性和有效性。方法33例患者34条患肢,单纯性大隐静脉曲张10条,原发性深静脉瓣膜功能不全20条,左髂静脉受压综合征2条,下肢静脉畸形-骨肥大-皮肤血管瘤综合征2条。3种治疗方式：①大隐静脉主干射频闭锁联合股浅静脉瓣膜包窄术、大隐静脉高位结扎和曲张属支浅静脉腔内激光（EVLT）治疗4条肢体：②大隐静脉主干射频闭锁联合大隐静脉高位结扎和EVLT治疗28条肢体;③大隐静脉主干射频闭锁联合外侧畸形静脉高位结扎和EVLT治疗2条肢体。结果随访1～15个月,平均3．27个月,33例患者均取得满意的疗效。结论主干静脉腔内射频治疗下肢静脉功能不全操作简便、安全、有效、微创,联合EVLT和手术治疗,可扩大其应用范围。     

腔镜深筋膜下交通静脉结扎治疗下肢静脉曲张

目的　观察腔镜深筋膜下交通静脉结扎 (SEPS)在下肢静脉曲张治疗中的疗效。　方法　 1 999年 1 1月～ 2 0 0 0年 1 2月手术治疗静脉曲张 1 0 8例 ,其中 34例 41侧患肢行 SEPS。男 1 6例 ,女 1 8例 ,年龄 2 0～ 79岁。病程 1～45年 ,平均 1 6.1年。双下肢病变 7例。 2 6例 30侧患肢有静脉性溃疡 ,溃疡直径 1 .5～ 1 2 .0 cm不等 ;8例 1 1侧患肢有色素沉着 ,皮肤病损 1个月～ 1 5年。根据病情分别或同时选用大隐静脉高位结扎和抽剥、小腿曲张浅静脉连续环形缝扎、股静脉瓣膜外修复成形和 SEPS术。　结果　 34例手术顺利 ;术后 1 9侧患肢溃疡 1个月内愈合 ,7侧患肢溃疡 3个月内愈合 ,4侧患肢行游离植皮后溃疡愈合。经术后 9～ 2 2个月的随访 ,溃疡无复发。　结论　 SEPS促进了静脉性溃疡的愈合 ,是治疗下肢静脉功能不全的重要方法之一。     

下肢静脉性溃疡的外科微创治疗

目的探讨下肢静脉性溃疡外科微创治疗的效果。方法对31例(33侧患肢)下肢静脉性溃疡通过静脉造影检查明确引起溃疡的原发病变,根据患肢血流动力学异常的种类和程度对10例(11侧患肢)行高位大隐静脉结扎联合静脉腔内激光治疗术;17例(18侧患肢)行高位大隐静脉结扎联合静脉腔内激光治疗、内镜深筋膜下交通静脉离断术;4例(4侧患肢)行高位大隐静脉结扎联合静脉腔内激光治疗、内镜深筋膜下交通静脉离断和股浅静脉瓣膜包窄术。溃疡一律行周缘环行缝扎。结果术后33侧患肢浅静脉曲张均消失,色素沉着、湿疹样病变均明显减轻;24侧小腿酸胀沉重感、疼痛、水肿12~16d消失;溃疡18~40d内愈合。随访1~36个月,平均14.8月,3侧(9.1%)肢体溃疡复发。结论纠正浅静脉、交通支静脉、深静脉功能不全和重视溃疡创面的处理是治疗下肢静脉性溃疡的有效疗法,静脉腔内激光治疗、内镜深筋膜下交通静脉离断术操作简便、微创、安全,联合股浅静脉瓣膜包窄术可以有效地减少下肢静脉性溃疡的复发。     

筋膜下内镜交通支离断术治疗下肢静脉性溃疡的体会

目的:探讨深筋膜下内镜交通支静脉离断术(subfascial endoscopic perforator surgery,SEPS)治疗下肢静脉性溃疡的可行性及应用价值。方法:回顾分析2008年12月至2011年4月为7例(8条肢体)下肢静脉性溃疡伴下肢静脉交通支瓣膜功能不全患者行大隐静脉剥脱术及SEPS的临床资料。结果:7例(8条肢体)手术均获成功,曲张静脉团块消失,下肢静脉血淤滞得到解决,色素沉着减轻,溃疡愈合。术后随访1～3年,无一例复发。结论:SEPS适于治疗下肢静脉交通支瓣膜功能不全的下肢静脉性溃疡患者,手术创伤小、安全、简单、易行,疗效确切,应用价值较高。     

腔内激光治疗静脉曲张的探讨

摘要：目的: 探讨腔内激光(EVLT)联合手术个性化治疗静脉曲张的综合方法。方法:下肢慢性静脉功能不全（CVI）285例（295条患肢），根据临床表现和双功超声、静脉造影，基于CEAP分期，分为A，B，C 3组，采取3种手术方式进行治疗。A组用单纯腔内激光闭塞术;B组用腔内激光加点式结扎；C组用股浅静脉包窄术加腔内激光加点式结扎。结果:全组曲张浅静脉均消失，皮肤颜色变浅，肿胀改善，溃疡愈合或缩小。结论:EVLT技术治疗下肢浅静脉曲张是有效的微创手术治疗方法，只要根据CEAP分期，通过标准化的诊断，选择好适应证，采用EVLT联合其他手术治疗原发性下肢深静脉瓣膜功能不全是可行和有效的。     

腔镜在下肢静脉性溃疡治疗中的应用

目的探讨腔镜在下肢慢性静脉功能不全(CVI)并发静脉性溃疡中的临床治疗经验与疗效。方法回顾性分析2004年5月至2011年4月期间我院应用腔镜治疗78例(88条患肢)下肢CVI并发静脉性溃疡患者的临床资料,患者均行大隐静脉高位结扎+腔内激光治疗(EVLT)+腔镜深筋膜下交通静脉离断术(SEPS)。结果所有患者手术顺利。SEPS手术时间15～30min,平均20min;术中出血量1～5ml,平均2ml;术后住院时间2～8d,平均5d。术后肢体酸胀感和曲张浅静脉消失,色素沉着区缩小。术后筋膜下血肿3例,皮下气肿2例,小腿胫前区及足靴区麻木感3例。所有患者4～6周溃疡愈合,随访0.5～5年,平均3.5年,仅1例复发,是由于足靴区交通静脉残留。结论 SEPS是治疗CVI并发静脉性溃疡的首选方法,具有创伤小、出血少、手术时间短、恢复快、并发症少、疗效显著等特点。     

Endovenous laser treatment combined with a surgical strategy for treatment of venous insufficiency in lower extremity: a report of 208 cases

BACKGROUND: We assessed the safety and efficacy of endovenous laser treatment (EVLT) of the saphenous vein combined with a surgical strategy for treatment of deep venous insufficiency in the lower extremity. METHODS: Two hundred thirty venous insufficiencies of the lower limbs in 208 consecutive patients (93 men and 115 women; mean age, 54.15 years) were treated with EVLT combined with surgical strategies. All patients were symptomatic. There were 84 limbs (36.5%) in C(2), 25 (10.9%) in C(3), 109 (47.7%) in C(4), 1 (0.4%) in C(5), and 9 (3.9%) in C(6) (CEAP), and Klippel-Trenaunay syndrome was present in 2 limbs. A total of 119 (51.7%) had perforator vein incompetence. Four therapeutic methods were included in this series according to symptoms, CEAP classification, and venous reflux. Simple EVLT was performed for 15 patients with only great saphenous vein (GSV) incompetence or Klippel-Trenaunay syndrome in 19 lower limbs. EVLT combined with high ligation of the GSV and open ligation of perforators was performed for 5 patients with GSV and perforator incompetence in 5 lower limbs. EVLT was combined with high ligation of the GSV for 76 patients with GSV incompetence in 94 lower limbs. EVLT was combined with external banding of the first femoral venous valve and high ligation of the GSV for 112 patients with primary deep venous insufficiency in 112 lower limbs. All patients were followed up on an outpatient basis for physical examinations and postoperative complaints, and duplex ultrasonography was performed 2 weeks, 6 months, and 1 year after operation. RESULTS: All patients tolerated the procedure well and returned to normal daily activities immediately, achieving a 100% immediate clinical success rate. Spot skin burn injuries occurred in 2 patients (1.0%). Paresthesia in the gaiter area was noted in 15 patients (7.2%). No postprocedural symptomatic deep venous thrombosis or pulmonary embolism occurred. Three patients had local recurrent varicose veins in the calf (1.4%) during a 2- to 27-month follow-up (mean, 6.12 months). Postoperative clinical classes were significantly improved between 2 weeks and 24 months (P = .0001 at 2 weeks and 3 to 18 months; P = .0055 at 24 months compared with before operation), especially in preoperative C(2) to C(3) stage patients, who achieved complete amelioration. CONCLUSIONS: EVLT is a novel minimally invasive treatment with advantages of safety, effectiveness, and simplicity, and it leaves no scars. Its indications can be expanded by combining EVLT with surgical strategies.     

Mid-term recurrence rate of incompetent perforating veins after combined superficial vein surgery and subfascial endoscopic perforating vein surgery

BACKGROUND: This study investigated the mid-term (mean, 3.7 years) clinical results and the results of duplex Doppler sonographic examinations of subfascial endoscopic perforating vein surgery (SEPS) in patients with mild to severe chronic venous insufficiency (clinical class 2-6) and assessed the factors associated with the recurrence of insufficient perforating veins (IPVs). METHODS: Eighty patients with mild to severe chronic venous insufficiency undergoing SEPS were evaluated, and duplex findings, as well as clinical severity and disability scores before and after the operation, were compared. Patients with prior deep vein thrombosis (<6 months) or prior SEPS were excluded from this study. RESULTS: There were 27 men and 53 women with a median age of 59.8 years (range, 34.3-80.0 years). The distribution of clinical classes (CEAP) was as follows: class 2, 13.1% (12 limbs); class 3, 22.8% (21 limbs); class 4, 19.6% (18 limbs); class 5, 21.7% (20 limbs); and class 6, 22.8% (21 limbs). The etiology of venous insufficiency was primary valvular incompetence in 83 limbs (90.2%) and secondary disease in 9 limbs (9.8%). Concomitant superficial vein surgery was performed in 89 limbs (95.7%). Twenty (95%) leg ulcers healed spontaneously within 12 weeks after operation, whereas one patient required additional split-thickness skin grafting. Eighteen patients had previous surgery of the great and/or short saphenous vein before SEPS. During a mean follow-up of 3.7 years, recurrence of 22 IPVs was observed in 20 (21.7%) of 92 limbs, and recurrent leg ulcers were observed in 2 (9.5%) of 21 limbs. We performed univariate and multivariate analyses to predict factors influencing the recurrence of IPVs (recurrent superficial varicosis, secondary disease, active or healed leg ulcer [C5/6], compression treatment, and previous operation). On multivariate analysis, previous surgery (P = .014) was identified as the only significant factor for the recurrence of IPVs. CONCLUSIONS: SEPS is a safe and highly effective treatment for IPVs. Within a median follow-up period of 3.7 years, only 2 of 21 venous ulcers recurred, both in patients with secondary disease. Nevertheless, we observed recurrence of IPVs in 21.7% of the operated limbs. On multivariate analysis, patients who had undergone previous surgery were found to have a significantly higher rate of recurrence.     

Great Saphenous Vein Stripping with Liberal Use of Subfascial Endoscopic Perforator Vein Surgery (SEPS)

This study is based on a unique registry of 632 patients who underwent great saphenous vein (GSV) stripping and liberal use of subfascial endoscopic perforator vein surgery (SEPS) for minimal to severe lower limb venous insufficiency. Clinical examinations and color-coded duplex scanning were performed on a randomly selected, manageable sample of 170 limbs to assess the affect of early SEPS on junctional (saphenofemoral [SFJ] and/or saphenopopliteal [SPJ]) and perforator vein (PV) insufficiencies and superficial varicosities at a median of 6.5 years. PV incompetence was present in 68 legs (40%), as the sole transfascial insufficiency in 28 limbs and combined with SFJ or SPJ incompetence in 40 limbs. Junction incompetence alone characterized an additional 38 limbs, bringing the total transfascial insufficiency prevalence to 62%. Superficial varicosities affected 46% of limbs. Overall CEAP clinical class was unimproved beyond preoperative values. PV incompetence was associated with higher CEAP and clinical venous severity scores than were junctional insufficiencies alone. We concluded that PV incompetence alone or combined with junctional insufficiency is associated with increased symptoms and disease progression. The prevalence of SFJ, SPJ, and PV incompetence (62%) and recurrent varicosities (46%) suggests that early use of SEPS does not prevent disease progression and offers no benefit over GSV stripping in the absence of deep vein insufficiency or threatened ulceration.